Cita APA

Kubo, T., Yamamoto, H., Lockwood, W. W., Valencia, I., Soh, J., Peyton, M., . . . Toyooka, S. (2009). MET gene amplification or EGFR mutation activate MET in lung cancers untreated with EGFR tyrosine kinase inhibitors.

Chicago Style Citation

Kubo, Takafumi, et al. MET Gene Amplification or EGFR Mutation Activate MET in Lung Cancers Untreated With EGFR Tyrosine Kinase Inhibitors. 2009.

Cita MLA

Kubo, Takafumi, et al. MET Gene Amplification or EGFR Mutation Activate MET in Lung Cancers Untreated With EGFR Tyrosine Kinase Inhibitors. 2009.